Royal Bank of Canada Cuts Prothena (NASDAQ:PRTA) Price Target to $20.00
Prothena (NASDAQ:PRTA – Free Report) had its price target cut by Royal Bank of Canada from $24.00 to $20.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have a sector perform rating on the biotechnology company’s stock. Several other equities research analysts have also weighed in on PRTA. Bank of […]
Prothena (NASDAQ:PRTA – Free Report) had its price target cut by Royal Bank of Canada from $24.00 to $20.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have a sector perform rating on the biotechnology company’s stock. Several other equities research analysts have also weighed in on PRTA. Bank of […]
